deoxyepinephrine has been researched along with dihydroergotoxine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dei Cas, L; Memo, M; Metra, M; Missale, C; Sigala, S; Spano, PF | 1 |
| Cas, LD; Metra, M; Missale, C; Spano, PF | 1 |
2 trial(s) available for deoxyepinephrine and dihydroergotoxine
| Article | Year |
|---|---|
Inhibition of aldosterone secretion by dopamine, ibopamine, and dihydroergotoxine in patients with congestive heart failure.
Topics: Aged; Aldosterone; Deoxyepinephrine; Depression, Chemical; Dihydroergotoxine; Dopamine; Dopamine Agents; Heart Failure; Humans; Male; Middle Aged; Random Allocation; Renin; Renin-Angiotensin System | 1989 |
Dopaminergic drugs in congestive heart failure: hemodynamic and neuroendocrine responses to ibopamine, dopamine, and dihydroergotoxine.
Topics: Administration, Oral; Aged; Aldosterone; Analysis of Variance; Blood Pressure; Deoxyepinephrine; Dihydroergotoxine; Dopamine; Dopamine Agonists; Epinephrine; Heart Failure; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Norepinephrine; Radionuclide Imaging; Renin; Stroke Volume; Vascular Resistance | 1995 |